Rosenberg, Daniel W. External Author

Publications

Sort by

Selected publications

  • A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectumCancer Prevention Research2015 Academic Article GET IT